Heart Disease News and Research

Latest Heart Disease News and Research

IBM discovers biodegradable nanoparticles that seek out and destroy drug-resistant bacteria

IBM's announcement of the first biodegradable nanoparticles that can seek out and destroy drug-resistant bacteria caps off a century of healthcare and life sciences innovation from IBM.

8 Apr 2011

Caffeine disrupts glucose metabolism and may contribute to type 2 diabetes

A growing body of research suggests that caffeine disrupts glucose metabolism and may contribute to the development and poor control of type 2 diabetes, a major public health problem.

8 Apr 2011

Refined carbohydrates create an ill and obese population

When it comes to feeding a body well, we've all been told we need proteins, fats and carbohydrates. For years, many of those we trust for health information have told us that the foundation of our diet should primarily consist of carbohydrates, namely, grains, breads and pastas.

8 Apr 2011

Cosmic radiation can increase risk of atherosclerosis in astronauts

Astronauts anticipate more trips to the moon and manned missions to Mars. But exposure to cosmic radiation outside the Earth's magnetic field could be detrimental to their arteries, according to a study by University of Alabama at Birmingham researchers published April 6, 2011, online in the journal Radiation Research.

8 Apr 2011

Longer looks: Could Ryan's plan be a pitfall for Democrats?; the cost of military health care; revealing more about doctors' billing practices

Every week, reporter Jessica Marcy selects interesting reading from around the Web.

8 Apr 2011

Virtual reality games can improve motor function in stroke patients

Virtual reality and other video games can significantly improve motor function in stroke patients, according to research from St. Michael's Hospital.

8 Apr 2011

BioParadox's VitaKine PCT can serve as promising therapy for heart attack patients

BioParadox, Inc., a regenerative medicine company pioneering point-of-care biologic treatments for cardiovascular disease, today announced data supporting the use of VitaKine- Platelet Cell Therapy as a promising treatment for heart attack patients.

8 Apr 2011

ZOLL begins shipments of new AED Plus version as per AHA, ERC Guidelines

ZOLL® Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that it has begun shipments of a new version of its AED Plus that is fully compliant with the new American Heart Association and European Resuscitation Council Guidelines issued in October of 2010.

8 Apr 2011

NSU to introduce new physical therapy program in Tampa

Nova Southeastern University will have a grand opening ceremony on Thursday, April 27 to launch the university's first physical therapy program in the Tampa Bay area.

8 Apr 2011

Blood pressure's internal circadian rhythm does not appear to increase morning heart attacks

The internally-driven daily cycle of blood pressure changes doesn't appear to be linked to the known increase in morning heart attacks, according to a study in Circulation Research: Journal of the American Heart Association.

8 Apr 2011

Shionogi launches CUVPOSA for pediatric chronic severe drooling

Shionogi Inc., the U.S.-based group company of Shionogi & Co., Ltd., today announced the U.S. commercial availability of CUVPOSA™ (glycopyrrolate) oral solution, the first and only FDA-approved treatment to reduce chronic severe drooling in patients aged 3 to 16 with neurologic conditions associated with problem drooling, such as cerebral palsy.

7 Apr 2011

BIOTRONIK donates ICD and pacemaker to 75 cardiac patients in Trinidad & Tobago

BIOTRONIK SE Co. & KG, a leading manufacturer of implantable cardiac devices, has provided a donation of implantable cardiac defibrillators and pacemaker device implants to more than 75 low-income and impoverished patients in the Republic of Trinidad & Tobago as part of its collaboration with Heartbeat International Foundation Inc.

7 Apr 2011

Alexion submits Soliris marketing applications to FDA, EMA for aHUS treatment

Alexion Pharmaceuticals, Inc. announced today that the company has submitted marketing applications to the U.S. Food and Drug Administration and the European Medicines Agency for Soliris as a treatment for patients with atypical Hemolytic Uremic Syndrome.

7 Apr 2011

Exercising during pregnancy improves child's heart health after birth

Moms-to-be long have been told by their doctors and baby-related books and websites that staying fit during pregnancy is good for both mother and child. When it was reported a couple of years back that exercising strengthens a fetus' heart control, many pregnant women took heed and hit the ground running, literally. Some signed up for prenatal yoga classes; others found new ways to incorporate low-impact aerobic activities into their daily lives.

7 Apr 2011

Reaction to GOP budget proposal swift, includes concern, support and political intrigue

After the budget proposal's release, reaction came from across the political and health industry spectrum. For instance, providers expressed concerns about reshaping Medicare and Medicaid. Possible GOP presidential hopefuls offered support, yet were viewed by some as "walking a tight rope."

7 Apr 2011

TBL1 levels may help identify obese persons at risk of developing fatty liver

Excess fat around the hips and belly may not really be compatible with current beauty ideals, but, to a certain degree, it is a normal, even vital energy store of our body. However, it is a different matter if the organism stores fat in organs such as the liver, pancreas or muscles. This is a clear sign of a metabolic disorder.

7 Apr 2011

Persistent fatigue in breast cancer survivors may be caused by autonomic nervous system running in overdrive

The persistent fatigue that plagues one out of every three breast cancer survivors may be caused by one part of the autonomic nervous system running in overdrive, while the other part fails to slow it down.

7 Apr 2011

Patients with type 2 diabetes can benefit from metformin than other drugs

New research suggests that several commonly prescribed drugs for type 2 diabetes may not be as effective at preventing death and cardiovascular diseases, such as heart attacks and stroke, as the oral anti-diabetic drug, metformin.

7 Apr 2011

Cliffside encourages patients to continue antidepressant use despite health risks

Cliffside Malibu, one of America's leading drug and alcohol treatment centers, is strongly urging its patients who are currently taking antidepressants not to stop, despite a new study and subsequent media reports that such drugs could raise the risk of heart attack or stroke in middle-age men taking the medications.

7 Apr 2011

Navigator-3 gene plays a key role in liver development

Scientists of the Max Delbr-ck Center for Molecular Medicine Berlin-Buch have demonstrated for the first time that a gene regulating neuronal cell migration during embryogenesis also plays a role in the development of the liver.

7 Apr 2011